These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7139977)

  • 1. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.
    Garden A; Davey DA; Dommisse J
    Clin Exp Hypertens B; 1982; 1(2-3):371-83. PubMed ID: 7139977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous flow perfusion of dihydralazine during pregnancy toxemia. Favorable outcome].
    Bernard-Muller S; Lauvergeon B; Letellier N; Merouani A; Tessier J; Tostivint R
    Anesth Analg (Paris); 1977; 34(6):1257-62. PubMed ID: 613876
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
    Ashe RG; Moodley J; Richards AM; Philpott RH
    S Afr Med J; 1987 Mar; 71(6):354-6. PubMed ID: 3551127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
    Thibonnier M; Lardoux MD; Corvol P
    Br J Clin Pharmacol; 1980 Jun; 9(6):561-7. PubMed ID: 6992823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
    Muhammad S; Usman H; Dawha YM; Yahya A; Yekeen A; Bako B
    Pregnancy Hypertens; 2022 Aug; 29():1-6. PubMed ID: 35605426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia.
    Shi DD; Yang FZ; Zhou L; Wang N
    J Clin Pharm Ther; 2016 Dec; 41(6):657-661. PubMed ID: 27578562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
    Kausar M; Husain S; Hussain R
    Afr Health Sci; 2023 Mar; 23(1):320-325. PubMed ID: 37545898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine.
    Bhorat IE; Naidoo DP; Rout CC; Moodley J
    Am J Obstet Gynecol; 1993 Apr; 168(4):1292-6. PubMed ID: 8475977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy.
    Michael CA
    Aust N Z J Obstet Gynaecol; 1986 Feb; 26(1):26-9. PubMed ID: 3524548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil.
    Wacker J; Werner P; Walter-Sack I; Bastert G
    Nephrol Dial Transplant; 1998 Feb; 13(2):318-25. PubMed ID: 9509441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dihydralazine infusion on the fetoplacental blood flow and maternal prostanoids.
    Jouppila P; Kirkinen P; Koivula A; Ylikorkala O
    Obstet Gynecol; 1985 Jan; 65(1):115-8. PubMed ID: 3838110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
    Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
    J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of dihydralazine infusion in the management of severe hypertension in pregnancy.
    Moodley J; Vasant RV
    Cent Afr J Med; 1986 Jun; 32(6):145-7. PubMed ID: 3568122
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
    Hjertberg R; Faxelius G; Lagercrantz H
    J Perinat Med; 1993; 21(1):69-75. PubMed ID: 8487154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
    Lamming GD; Broughton Pipkin F; Symonds EM
    Clin Exp Hypertens (1978); 1980; 2(5):865-95. PubMed ID: 7428566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
    Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.